Marina Dobrovolskaia
机构: Sr.Principal Scientist, Nanotechnology Characterization Lab, NCI, LBR
每年引用次数
引用次数
引用: 17,923
H-指数: 55
I10-指数 : 112
出版物: 288
126 Relationship Between Complement Factors and CC Chemokines and the Pharmacokinetics (PK) and Pharmacodynamics (PD) of PEGylated Liposomal Doxorubicin (PLD) in Patients with Refractory Epithelial Ovarian Cancer (EOC)
G. Song , S. Moore , T. Tarrant , M. Dobrovolskaia
European Journal of Cancer 48 39 -40
3
2012
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.
A N Ilinskaya , M A Dobrovolskaia
British Journal of Pharmacology 171 ( 17) 3988 -4000
67
2014
Dendrimers Effects on the Immune System: Insights into Toxicity and Therapeutic Utility.
Marina A. Dobrovolskaia
Current Pharmaceutical Design 23 ( 21) 3134 -3141
20
2017
Goode A Graham LM Hartung T
JPM Almeida , M Bachmann , W Bäumer , S Bergin
A comprehensive study comparing on-and off-target levels of the most common forms of CRISPR/Cas9 guide RNAs
A Jacobi , G Rettig , M Schubert , J Shapiro
EUROPEAN JOURNAL OF HUMAN GENETICS 27 788 -789
2019
Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication. Aggeli A Amati M
M Azzawi , L Ballerini , R Banerjee , D Baumann
Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication.
S Avnet , M Blanco-Prieto , J Bonde , F Bost
Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication.
S Avnet , M Blanco-Prieto , J Bonde , F Bost
Hall JB Hernandez-Alcoceba R Hou S Hsieh M Jeong JM
A Baker , G Bao , A Bianco , AC Bradshaw
Relationship between complement factors and CC chemokines and the pharmacokinetics (PK) and pharmacodynamics (PD) of PEGylated liposomal doxorubicin (PLD) in patients with refractory epithelial ovarian cancer (EOC)
G Song , S Moore , T Tarrant , M Dobrovolskaia
EUROPEAN JOURNAL OF CANCER 48 39 -40
2
2012
Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication.
R Alemany , MJ Alonso , Andriola Silva AK , H Azzazy
Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication. Abdulla A Berry C
K Braeckmans , C Brandenberger , J Card , D Chari
Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication.
JPM Almeida , M Bachmann , W Bäumer , S Bergin
Identifying and Assessing Biomaterial Nanotoxicity in Translational Research for Preclinical Drug Development
DY FURGESON , MA DOBROVOLSKAIA
Advanced drug delivery reviews 61 ( 6)
2009
Handbook Of Immunological Properties Of Engineered Nanomaterials
Marina A Dobrovolskaia , Scott E McNeil
31
2016
Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier
Kirill A Afonin , Marina A Dobrovolskaia , Neill J Liptrott , Jeffrey D Clogston
Molecules 26 ( 3) 652
2021
Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.
Mihály Józsi , Balázs Győrffy , Marina A Dobrovolskaia , Tamás Mészáros
Frontiers in Immunology 12 642860 -642860
2021
Characterization of nanoparticles for therapeutics.
Jennifer B Hall , Marina A Dobrovolskaia , Anil K Patri , Scott E McNeil
Nanomedicine: Nanotechnology, Biology and Medicine 2 ( 6) 789 -803
259
2007
RNA-DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-κB in human cells.
Weina Ke , Enping Hong , Renata F Saito , Maria Cristina Rangel
Nucleic Acids Research 47 ( 3) 1350 -1361
67
2019
Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
Marina A Dobrovolskaia , Scott E McNeil
Expert Opinion on Drug Delivery 12 ( 7) 1163 -1175
27
2015